Medicine and Dentistry
Pulmonary Hypertension
100%
Programmed Death 1 Ligand 1
66%
Bleomycin
33%
Myeloid-Derived Suppressor Cell
33%
Myelopoiesis
33%
Emergency
33%
Combination Therapy
22%
Myeloid Cell
22%
Pulmonary Fibrosis
22%
Therapeutic Procedure
22%
Antibody
11%
Cell Proliferation
11%
Transplantation
11%
Prophylaxis
11%
Chronic Lung Disease
11%
Diphtheria Toxin
11%
Exhaustion
11%
Development
11%
Heart Protection
11%
Heart Right Ventricle Pressure
11%
Heart Ventricle Remodeling
11%
Pressure Measurement
11%
Interstitial Lung Disease
11%
Immunocompetent Cell
11%
Cells
11%
Tissues
11%
Assessment
11%
Mechanism of Action
11%
Patient
11%
Lung
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Programmed Death 1 Ligand 1
66%
Bleomycin
33%
Mouse
33%
Emergency
33%
Lung Fibrosis
22%
Vascular Remodeling
22%
Antibody
11%
Diphtheria Toxin
11%
Comorbidity
11%
Exhaustion
11%
Heart Ventricle Remodeling
11%
Chronic Lung Disease
11%
Interstitial Lung Disease
11%